BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Total revenue from sales of goods and services
3Y CAGR
+47.8%/yr
vs +90.3%/yr prior
5Y CAGR
+117.9%/yr
Recent deceleration
Acceleration
-42.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
49.1x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $874.84M | +94.1% |
| 2024 | $450.71M | +36.0% |
| 2023 | $331.41M | +22.4% |
| 2022 | $270.83M | +72.3% |
| 2021 | $157.17M | +782.4% |
| 2020 | $17.81M | -63.5% |
| 2019 | $48.84M | +136.5% |
| 2018 | $20.65M | -18.0% |
| 2017 | $25.19M | -4.4% |
| 2016 | $26.35M | - |